GMP Manufacturing
Stemlab Advanced holds a Manufacturing Authorisation for the production of Investigational Medicinal Products (IMPs) since 2020.
We combine a long track record of processing, banking and releasing of cellular therapy products with a rigorous compliance with current GMP guidelines to deliver an IMP that meets our clients’ requirements and within the established timelines and budget.
Our facilities are equipped with state-of-the-art equipment prepared for multi-products manufacture for clinical trials and hospital exemptions.
